AcuamarkDx

New York, NY · Founded 2012 · Privately Held (backing)

Developer of a cancer screening blood technology designed to detect cancer markers at early stages. AcuamarkDx is based in New York, NY and was founded in 2012. Its last reported valuation was $85 million in Jun 2024. It has raised $25 million.

Last reported valuation

$85.0M

Oct 2026

Priced at

—

Total raised

$25.0M

Last round

—

How much has AcuamarkDx raised?

$25.0Macross 0 recorded rounds

Free account

More of AcuamarkDx with a free account

·Watch AcuamarkDx: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

AcuamarkDx investors

5 investors are on record for AcuamarkDx, including 1955 Capital, Bruker, Cornell University and HBS Alumni Angels of Greater New York.

For fundraisers

Raising for a company like AcuamarkDx?

5 investors have backed AcuamarkDx.

See all 5 investors →

Frequently asked about AcuamarkDx

How much has AcuamarkDx raised?: AcuamarkDx has raised $25.0M in total across 0 recorded funding rounds.